Learn More
Apexbio Technology LLC Miltefosine, 50mg. Cas: 58066-85-6 MFCD: MFCD00133396. PI3K/Akt inhibitor

Supplier: Apexbio Technology LLC B137150

Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 uM and 8.1 uM in carcinoma cell lines A431 and HeLa, first oral drug for Visceral leishmaniasis, effective against both promastigotes and amastigotes. Phase 4. 58066-85-6. MFCD00133396
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.